Bioarray Therapeutics
New Haven, US · Delaware corporation
Healthtech
Founders & leadership
MF
Marcia FournierExecutive Officer, Director
HK
Henry KayDirector
MP
Michael PremingerDirector
PO
Patrick O'NeillDirector
UR
Una RyanDirector
Reported raises · per SEC filings
Form D private placements▶$5.2MraisedSep 2017 · 20 investors · Other Health CareRule 506(b)
▶$5.2MraisedSep 2017 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marcia FournierExecutive Officer, Director
- Henry KayDirector
- Zafrira AvnurDirector
- Pauline MurphyDirector
- Pamela LaytonExecutive Officer, Director
- Michal PremingerDirector
- Jim LaFranceDirector
- Offering amount
- $5.2M
- Amount sold
- $5.2M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMay 2015 · 22 investors · Other Health CareRule 506(b)
▶$1.5MraisedMay 2015 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Henry KayDirector
- Michael PremingerDirector
- Patrick O'NeillDirector
- Una RyanDirector
- Marcia FournierExecutive Officer, Director
- Offering amount
- $2.9M
- Amount sold
- $1.5M
- Proceeds to insiders
- $150K
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.